Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

Drug manufacturer reimbursement vendor Kalderos expects “a number of manufacturers” will begin using its 340B Pay software platform during the first quarter of 2021, the company told 340B Report last night. “We are fielding a high level of interest from drug manufacturers of all sizes,” the company said.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report